Buyout Buzz Sends Cynapsus Therapeutics Inc (CYNA) to Record High

Cynapsus Therapeutics Inc (CYNA) agreed to be acquired in a $624 million all-cash deal

Sep 1, 2016 at 10:25 AM
facebook X logo linkedin


Canadian pharmaceutical stock Cynapsus Therapeutics Inc (NASDAQ:CYNA) is the Nasdaq's top performer by a mile this morning, shooting 116% higher to $39.67 after private firm Sunovion Pharmaceuticals Inc. agreed to buy the company for $624 million in an all-cash deal. The agreement values CYNA at $40.50 per share -- a previously uncharted level, to which BMO promptly raised its price target.

As it happens, CYNA was surrounded by bullish sentiment even before the buyout news. All four of the brokerage firms tracking the stock already held a "strong buy" recommendation. And short interest represents just 2.8% of the stock's available float. In fact, these pessimistic bets fell by more than 13% during the most recent two-week reporting period.

Meanwhile, though options volume on the stock has been nearly nonexistent, calls account for roughly 98% of the total open interest. Plus, every option bought to open in the last two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) was a call.

Technically, CYNA has deserved all this upbeat attention. Heading into today's session, the shares were already up 20% year-to-date, and had been riding atop support from their 40-day moving average since late May. Obviously, shareholders should be thrilled by recent developments, as today's bull gap earlier put Cynapsus Therapeutics Inc (NASDAQ:CYNA) at an all-time high of $39.74.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI